resisttb
- Sep 3, 2020
- 1 min read

CHMP Grants Positive Opinion for Expanded Use of Otsuka’s Deltyba® (delamanid) in Children and Adole

Updated: Oct 4, 2020

The European Medicines Agency has updated its stance on Deltyba—with implications for children with DR-TB.

Read about it here.

1 view0 comments

Recent Posts

Updated Clinical Trial Progress Report

View our freshly updated TB clinical trial progress report on our website or download it below.

10

Overcoming Pediatric Drug-Resistant TB Crisis

Special message from Dr. Tereza Kasaeva, Director of WHO's Global TB Program, on the occasion of World Children's Day and World Antimicrobial Awareness Week. Read it here.

30

WHO Joins Forces with Stakeholders for Improved Pediatric Access

WHO and other stakeholders join forces to accelerate access to effective pediatric HIV and tuberculosis diagnostics and medicines Read the article here.

10